Journal for ImmunoTherapy of Cancer (Nov 2023)
897-B A DNAJB1-PRKACA fusion peptide vaccine combined with ipilimumab and nivolumab elicits polyclonal fusion-specific T cell responses in fibrolamellar carcinoma
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)